ACCESSION: MSBNK-SMB_Measured-HSA033P0173001
RECORD_TITLE: Uncharacterized; LC-ESI-QTOF; MS2; NEGATIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.15, Processed 2025.02.15, Annotated 2025.04.01, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Liang et al. J Pharm Biomed Anal. 2022, 214, 114718
COMMENT: This is an averaged mass spectra data created by integrating product ion scan data obtained from the follwing DDA dataset.
COMMENT: DATASET_ID MTBLS3854
COMMENT: DATASET_TITLE Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
COMMENT: DATASET_AUTHORS Xinjun Wang
COMMENT: MS1_M/Z_AVERAGED_THRES 20.000
COMMENT: MS2_M/Z_AVERAGED_THRES 20.000
COMMENT: DATASET_FILE_NUM 50
COMMENT: NUM_AVERAGED_SPEC 69
COMMENT: RAW_SPEC {'C16neg_4672': {'bp': 7839.0, 'sum': 22170.0}, 'C11neg_4589': {'bp': 7414.0, 'sum': 18471.0}, 'D102neg_4627': {'bp': 6769.0, 'sum': 18899.0}, 'C8neg_4557': {'bp': 6712.0, 'sum': 21075.0}, 'C9neg_4745': {'bp': 6556.0, 'sum': 19843.0}, 'C3neg_4680': {'bp': 6297.0, 'sum': 17631.0}, 'C7neg_4682': {'bp': 6257.0, 'sum': 17234.0}, 'C6neg_4733': {'bp': 6226.0, 'sum': 17782.0}, 'C1neg_4537': {'bp': 6165.0, 'sum': 19831.0}, 'C13neg_4631': {'bp': 6123.0, 'sum': 18418.0}, 'D207neg_4800': {'bp': 6123.0, 'sum': 16164.0}, 'C13neg_4642': {'bp': 6114.0, 'sum': 16707.0}, 'D87neg_4717': {'bp': 6093.0, 'sum': 17934.0}, 'C11neg_4601': {'bp': 6055.0, 'sum': 17954.0}, 'C1neg_4553': {'bp': 5845.0, 'sum': 14125.0}, 'C15neg_4436': {'bp': 5823.0, 'sum': 16369.0}, 'C16neg_4659': {'bp': 5663.0, 'sum': 15951.0}, 'C3neg_4670': {'bp': 5640.0, 'sum': 16453.0}, 'C8neg_4567': {'bp': 5567.0, 'sum': 16123.0}, 'C9neg_4736': {'bp': 5471.0, 'sum': 15917.0}, 'C5neg_4691': {'bp': 5468.0, 'sum': 17983.0}, 'C6neg_4721': {'bp': 5367.0, 'sum': 16072.0}, 'C7neg_4669': {'bp': 5325.0, 'sum': 17007.0}, 'D102neg_4618': {'bp': 5205.0, 'sum': 18379.0}, 'D147neg_4851': {'bp': 5019.0, 'sum': 16540.0}, 'C4neg_4588': {'bp': 4980.0, 'sum': 14633.0}, 'D207neg_4811': {'bp': 4978.0, 'sum': 16584.0}, 'D143neg_4625': {'bp': 4944.0, 'sum': 13741.0}, 'D143neg_4637': {'bp': 4876.0, 'sum': 14223.0}, 'D147neg_4838': {'bp': 4816.0, 'sum': 15115.0}, 'D64neg_4691': {'bp': 4782.0, 'sum': 12675.0}, 'C5neg_4702': {'bp': 4711.0, 'sum': 15693.0}, 'C12neg_4570': {'bp': 4668.0, 'sum': 11191.0}, 'D168neg_4666': {'bp': 4602.0, 'sum': 14153.0}, 'D87neg_4705': {'bp': 4567.0, 'sum': 14446.0}, 'C2neg_4692': {'bp': 4550.0, 'sum': 13582.0}, 'D171neg_4692': {'bp': 4416.0, 'sum': 13246.0}, 'C15neg_4425': {'bp': 4177.0, 'sum': 11982.0}, 'D168neg_4649': {'bp': 3953.0, 'sum': 12220.0}, 'D99neg_4669': {'bp': 3926.0, 'sum': 13399.0}, 'D126neg_4753': {'bp': 3869.0, 'sum': 12756.0}, 'C18neg_4626': {'bp': 3474.0, 'sum': 10513.0}, 'C2neg_4719': {'bp': 3462.0, 'sum': 10659.0}, 'D83neg_4878': {'bp': 3261.0, 'sum': 10817.0}, 'D170neg_4565': {'bp': 3186.0, 'sum': 9338.0}, 'D142neg_4666': {'bp': 3124.0, 'sum': 8955.0}, 'D136neg_4520': {'bp': 3102.0, 'sum': 8870.0}, 'D74neg_4559': {'bp': 2986.0, 'sum': 8503.0}, 'D66neg_4743': {'bp': 2793.0, 'sum': 8941.0}, 'C17neg_4496': {'bp': 2681.0, 'sum': 7417.0}, 'C12neg_4546': {'bp': 2675.0, 'sum': 8023.0}, 'D145neg_4621': {'bp': 2657.0, 'sum': 8912.0}, 'C4neg_4562': {'bp': 2499.0, 'sum': 8458.0}, 'D73neg_4670': {'bp': 2495.0, 'sum': 7278.0}, 'D178neg_4582': {'bp': 2442.0, 'sum': 7778.0}, 'D122neg_4879': {'bp': 2430.0, 'sum': 7263.0}, 'D121neg_4626': {'bp': 2397.0, 'sum': 7829.0}, 'D108neg_4723': {'bp': 2391.0, 'sum': 7777.0}, 'D119neg_4572': {'bp': 2305.0, 'sum': 6988.0}, 'D203neg_4463': {'bp': 2225.0, 'sum': 7035.0}, 'D145neg_4643': {'bp': 2010.0, 'sum': 5493.0}, 'D65neg_4640': {'bp': 1983.0, 'sum': 6782.0}, 'D203neg_4477': {'bp': 1925.0, 'sum': 6572.0}, 'D178neg_4590': {'bp': 1902.0, 'sum': 6057.0}, 'D94neg_4653': {'bp': 1631.0, 'sum': 5793.0}, 'D84neg_4676': {'bp': 1526.0, 'sum': 4470.0}, 'D124neg_4560': {'bp': 1262.0, 'sum': 4072.0}, 'D117neg_4833': {'bp': 1156.0, 'sum': 4246.0}, 'D146neg_4502': {'bp': 1057.0, 'sum': 3157.0}}
COMMENT: RETENTION_TIME_STDEV 0.011
COMMENT: PRECURSOR_M/Z_RAW 173.057073
COMMENT: PRECURSOR_M/Z_STDEV 0.000731
COMMENT: PRECURSOR_IN_MS1 mz 173.057148; int 999.000; delta(ppm) -0.150615
COMMENT: PROPOSED_CHARGE_STATE -1; mz 174.059621; int 58.802; cor 0.978
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M-H; M-H2O-H; mz 155.045808; int 38.628; cor 0.971
COMMENT: PROPOSED_ION_FORM M-H; M+Na-2H; mz 195.038487; int 13.146; cor 0.872
COMMENT: PROPOSED_ION_FORM M+FA-H; M-H2O-H; mz 109.040451; int 2.270; cor 0.838
COMMENT: PROPOSED_ION_FORM M+FA-H; M-H; mz 127.050873; int 43.446; cor 0.961
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 15.046; C5H11N4OP; [M-H]1; delta(ppm) -15.046153
COMMENT: PROPOSED_MF SevenGoldenRules 2.126; C6H10N2O4; [M-H]1; delta(ppm) 2.125650
COMMENT: PROPOSED_MF SevenGoldenRules 2.905; C5H8N2O2; [M+FA-H]1; delta(ppm) 2.904912
COMMENT: PROPOSED_MF MS-FINDER 4.266; C6H10N2O4; [M-H]-; delta(ppm) 2.141552
COMMENT: PROPOSED_MF MS-FINDER 4.256; C5H8N2O2; [M+FA-H]-; delta(ppm) 184919.559322
COMMENT: PROPOSED_MF MS-FINDER 2.139; C7H6N6; [M-H]-; delta(ppm) -5.586585
COMMENT: PROPOSED_MF SIRIUS5_Sirius 47.125; C6H10N2O4; [M-H]-; delta(ppm) 2.141552
COMMENT: PROPOSED_MF SIRIUS5_Sirius 47.125; C5H8N2O2; [M+CH2O2-H]-; delta(ppm) 1135300.095814
COMMENT: PROPOSED_MF SIRIUS5_Sirius -0.609; C9H9F3; [M-H]-; delta(ppm) -6.973689
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H8N2O2; [M+CH2O2-H]-; delta(ppm) 1135300.095814
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H10N2O4; [M-H]-; delta(ppm) 2.141552
COMMENT: PROPOSED_MF SIRIUS6_Sirius 71.259; C5H8N2O2; [M+CH2O2-H]-; delta(ppm) 1135300.095814
COMMENT: PROPOSED_MF SIRIUS6_Sirius 71.259; C6H10N2O4; [M-H]-; delta(ppm) 2.141552
COMMENT: PROPOSED_MF SIRIUS6_Sirius 50.101; C3H6N5O; [M+CH2O2-H]-; delta(ppm) 531014.375361
COMMENT: PROPOSED_MF SIRIUS6_Sirius 50.101; C4H8N5O3; [M-H]-; delta(ppm) 9.900144
COMMENT: PROPOSED_MF SIRIUS6_Sirius 39.048; C5H14N2OSi2; [M-H]-; delta(ppm) -269805.162682
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.725; C7H6N6; [M-H]-; delta(ppm) -5.586585
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.422; C3H9N7P; [M-H]-; delta(ppm) -7.372695
COMMENT: PROPOSED_MF SIRIUS6_Sirius 2.289; C7H11FN2S; [M-H]-; delta(ppm) 9.997180
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.391; C9H9F3; [M-H]-; delta(ppm) -6.973689
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H8N2O2; [M+CH2O2-H]-; delta(ppm) 1135300.095814
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H10N2O4; [M-H]-; delta(ppm) 2.141552
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.935; WLTXUKAQFBTJKS-UHFFFAOYNA-N; [M-H]-; NC(=O)C(CCC(O)=O)NC=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.670; NRXIKWMTVXPVEF-BYPYZUCNSA-N; [M-H]-; OC(=O)CC[C@H](NC=N)C(O)=O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.554; DCGWMLJPCYQFKA-UHFFFAOYSA-N; [M-H]-; O=C(O)CCC(NN=C)C(=O)O
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.308; QBPUMKFCXJOLEZ-UHFFFAOYSA-N; [M-H]-; O=C(O)C1C=C(C=2C=CC=CC21)C
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.258; QYHZCEGUXLBLDG-CLISUWTPNA-N; [M-H]-; N[C@@]1(CCC[C@@H]1[N+]([O-])=O)C(O)=O
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.723; NBAKTGXDIBVZOO-UHFFFAOYNA-N; [M+FA-H]-; Dihydrothymine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.300; NRXIKWMTVXPVEF-BYPYZUCNSA-N; [M-H]-; Formiminoglutamic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.213; VZSTVUJXUYNIOQ-UHFFFAOYNA-N; [M+FA-H]-; alpha-amino-gamma-cyanobutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.135; XZFMJVJDSYRWDQ-NZFOVINXNA-N; [M-H]-; (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.088; WIBZLKZAIBFAFQ-UHFFFAOYSA-N; [M+FA-H]-; UNPD180309
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.016; QYHZCEGUXLBLDG-CLISUWTPNA-N; [M-H]-; UNPD8794
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.010; WLTXUKAQFBTJKS-UHFFFAOYNA-N; [M-H]-; Formylisoglutamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 7.001; DXWQLTOXWVWMOH-UHFFFAOYNA-N; [M+FA-H]-; gamma-amino-gamma-cyanobutanoic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.968; YIROYDNZEPTFOL-UHFFFAOYSA-N; [M+FA-H]-; 5,5-dimethylhydantoin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.958; HXFOXFJUNFFYMO-BYPYZUCNSA-N; [M-H]-; N-Acetylasparagine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.913; DCGWMLJPCYQFKA-UHFFFAOYSA-N; [M-H]-; 2-(2-methylidenehydrazin-1-yl)pentanedioic acid
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.832; CQROFWZEURPZRP-UHFFFAOYSA-N; [M+FA-H]-; UNPD230472
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.682; XYVMBSCIEDOIJQ-UHFFFAOYSA-N; [M+FA-H]-; Squamolone
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.638; NPWMTBZSRRLQNJ-UHFFFAOYNA-N; [M+FA-H]-; Pyroglutamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.610; WGOIHPRRFBCVBZ-YEQUQEJONA-N; [M+FA-H]-; UNPD165324
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.560; ICCHEGCKVBMSTF-UHFFFAOYNA-N; [M+FA-H]-; L-Cyclo(alanylglycyl)
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.550; MTZDUNZYSCZQFT-YEQUQEJONA-N; [M+FA-H]-; UNPD79838
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.521; JYEMHOTUCUFTLO-UHFFFAOYSA-N; [M+FA-H]-; 1-ethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.502; JGBOVFKUKBGAJQ-UHFFFAOYSA-N; [M+FA-H]-; UNPD186074
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.474; HWYGBPPFPNZPGQ-NSCUHMNNSA-N; [M+FA-H]-; UNPD146457
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.466; GOFALJDPGWIYKL-UHFFFAOYSA-N; [M+FA-H]-; UNPD1614
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.454; LPQUIFIUJKZJRT-UHFFFAOYSA-N; [M+FA-H]-; 1-methyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.258; LAEXPJQUWCGDGC-UHFFFAOYSA-N; [M+FA-H]-; 1-methylpiperazine-2,6-dione
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.761; FAMRKDQNMBBFBR-UHFFFAOYSA-N; [M-H]-; ethyl N-ethoxycarbonyliminocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; WLTXUKAQFBTJKS-UHFFFAOYNA-N; [M-H]-; Formylisoglutamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; XYVMBSCIEDOIJQ-UHFFFAOYSA-N; [M+FA-H]-; Squamolone
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.937; WGOIHPRRFBCVBZ-YEQUQEJONA-N; [M+FA-H]-; UNPD165324
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.928; XZFMJVJDSYRWDQ-NZFOVINXNA-N; [M-H]-; (2R,4R)-4-aminopyrrolidine-2,4-dicarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.917; HXFOXFJUNFFYMO-BYPYZUCNSA-N; [M-H]-; N-Acetylasparagine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.896; DCGWMLJPCYQFKA-UHFFFAOYSA-N; [M-H]-; 2-(2-methylidenehydrazin-1-yl)pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.886; QYHZCEGUXLBLDG-CLISUWTPNA-N; [M-H]-; UNPD8794
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.884; NRXIKWMTVXPVEF-BYPYZUCNSA-N; [M-H]-; Formiminoglutamic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.841; VZSTVUJXUYNIOQ-UHFFFAOYNA-N; [M+FA-H]-; alpha-amino-gamma-cyanobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.803; JGBOVFKUKBGAJQ-UHFFFAOYSA-N; [M+FA-H]-; UNPD186074
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.790; MTZDUNZYSCZQFT-YEQUQEJONA-N; [M+FA-H]-; UNPD79838
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.790; LPQUIFIUJKZJRT-UHFFFAOYSA-N; [M+FA-H]-; 1-methyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.786; JYEMHOTUCUFTLO-UHFFFAOYSA-N; [M+FA-H]-; 1-ethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.783; NPWMTBZSRRLQNJ-UHFFFAOYNA-N; [M+FA-H]-; Pyroglutamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.774; HWYGBPPFPNZPGQ-NSCUHMNNSA-N; [M+FA-H]-; UNPD146457
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.767; DXWQLTOXWVWMOH-UHFFFAOYNA-N; [M+FA-H]-; gamma-amino-gamma-cyanobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.748; CQROFWZEURPZRP-UHFFFAOYSA-N; [M+FA-H]-; UNPD230472
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.696; WIBZLKZAIBFAFQ-UHFFFAOYSA-N; [M+FA-H]-; UNPD180309
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.669; NBAKTGXDIBVZOO-UHFFFAOYNA-N; [M+FA-H]-; Dihydrothymine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.669; GOFALJDPGWIYKL-UHFFFAOYSA-N; [M+FA-H]-; UNPD1614
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.665; ICCHEGCKVBMSTF-UHFFFAOYNA-N; [M+FA-H]-; L-Cyclo(alanylglycyl)
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.610; YIROYDNZEPTFOL-UHFFFAOYSA-N; [M+FA-H]-; 5,5-dimethylhydantoin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.555; LAEXPJQUWCGDGC-UHFFFAOYSA-N; [M+FA-H]-; 1-methylpiperazine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.235; FAMRKDQNMBBFBR-UHFFFAOYSA-N; [M-H]-; ethyl N-ethoxycarbonyliminocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.886; NRXIKWMTVXPVEF-BYPYZUCNSA-N; [M-H]-; (2S)-2-(aminomethylideneamino)pentanedioic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.812; NBAKTGXDIBVZOO-UHFFFAOYSA-N; [M+FA-H]-; 5-methyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.610; YIROYDNZEPTFOL-UHFFFAOYSA-N; [M+FA-H]-; 5,5-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.948; FAMRKDQNMBBFBR-UHFFFAOYSA-N; [M-H]-; ethyl N-ethoxycarbonyliminocarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.510; HXFOXFJUNFFYMO-BYPYZUCNSA-N; [M-H]-; (2S)-2-acetamido-4-amino-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.507; WLTXUKAQFBTJKS-BYPYZUCNSA-N; [M-H]-; (4S)-5-amino-4-formamido-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.313; NPWMTBZSRRLQNJ-VKHMYHEASA-N; [M+FA-H]-; (3S)-3-aminopiperidine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.250; LBKJJTGSZIPAFX-UHFFFAOYSA-N; [M-H]-; 5-(carbamoylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.239; ZADTVTGLZYNLTP-IUYQGCFVSA-N; [M-H]-; (2R,4S)-1-carbamoyl-4-hydroxypyrrolidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.190; XYVMBSCIEDOIJQ-UHFFFAOYSA-N; [M+FA-H]-; 2-oxopyrrolidine-1-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.182; FBYDNPVPBDAFFV-UHFFFAOYSA-N; [M-H]-; piperazine-2,5-dicarboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.167; FZLYWFSBVZNFHZ-BYPYZUCNSA-N; [M-H]-; (3S)-3-acetamido-4-amino-4-oxobutanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; FOFPBSAVHBTASA-UHFFFAOYSA-N; [M-H]-; 2-(4-hydroperoxy-2-oxopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.149; ZCASHLUDUSAKNN-UHFFFAOYSA-N; [M-H]-; 2-[(2-acetamidoacetyl)amino]acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; BJSCOTHGFJMOOE-UHFFFAOYSA-N; [M+FA-H]-; 5-oxopyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.023; XZQFGMJAIGQKHP-BYPYZUCNSA-N; [M+FA-H]-; N-[(3S)-2-oxopyrrolidin-3-yl]formamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; GVGGWUXGMRTNIK-UHFFFAOYSA-N; [M+FA-H]-; N-(2-amino-2-oxoethyl)prop-2-enamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; BLCZASRHXNXCGE-UHFFFAOYSA-N; [M+FA-H]-; 1,4,5,6-tetrahydropyrimidine-6-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.001; JOSUSMBJSISVHN-UHFFFAOYSA-N; [M+FA-H]-; 5-oxa-2,7-diazaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.996; KZUBZCHAWPDYQX-UHFFFAOYSA-N; [M+FA-H]-; 2-(2-cyanoethylamino)acetic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.994; KZVYITBTXCMVDP-UHFFFAOYSA-N; [M+FA-H]-; 4-methylpiperazine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; NVNPOFYSSSAIFL-UHFFFAOYSA-N; [M-H]-; 1-nitropiperidine-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.953; QQZIRAVAHFONDV-UHFFFAOYSA-N; [M+FA-H]-; 5-amino-3,4-dihydro-2H-pyrrole-2-carboxylic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.949; PVGKKACSLZHMQT-UHFFFAOYSA-N; [M+FA-H]-; 3-ethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.947; LEDCSKBMDLMRJG-UHFFFAOYSA-N; [M+FA-H]-; 2-(1,3-oxazol-2-ylamino)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.934; WCJZFXWWQURWGE-UHFFFAOYSA-N; [M+FA-H]-; 3,5-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.933; ZVHQEXASXNGICA-UHFFFAOYSA-N; [M+FA-H]-; 4-aminopiperidine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.928; WXKVEQXAOQPAKO-UHFFFAOYSA-N; [M+FA-H]-; 1-methylpiperazine-2,3-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.924; LPQUIFIUJKZJRT-UHFFFAOYSA-N; [M+FA-H]-; 1-methyl-1,3-diazinane-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.917; GYNOMCDGHQHGHJ-UHFFFAOYSA-N; [M+FA-H]-; 1-methylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.910; WCUWYKIMDAACPY-GSVOUGTGSA-N; [M+FA-H]-; (1R)-1-(5-methyl-1,3,4-oxadiazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.909; NZRGMYXITFOSJS-UHFFFAOYSA-N; [M+FA-H]-; 2-(5-methyl-1,3,4-oxadiazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; XNJHLZCLSPEUJN-UHFFFAOYSA-N; [M+FA-H]-; 3-methylpiperazine-2,6-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; DSOGRJSLWCABBW-UHFFFAOYSA-N; [M+FA-H]-; 3-(3-methyldiazirin-3-yl)propanoic acid
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; UPYVOKMHDMVAKU-UHFFFAOYSA-N; [M+FA-H]-; 3-(methylamino)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.904; GLEJFOKLZHFGPI-UHFFFAOYSA-N; [M+FA-H]-; 3-(aminomethyl)pyrrolidine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.871; JJWACYUTERPMBM-UHFFFAOYSA-N; [M+FA-H]-; 1-acetylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.830; AHGQESFVDCNOGJ-UHFFFAOYSA-N; [M+FA-H]-; ethyl N-(cyanomethyl)carbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; ICCHEGCKVBMSTF-UHFFFAOYSA-N; [M+FA-H]-; 3-methylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.789; IVFVSTOFYHUJRU-SQOUGZDYSA-N; [M-H]-; (3aR,5R,6R,6aS)-2-amino-5-(hydroxymethyl)-3a,5,6,6a-tetrahydrofuro[2,3-d][1,3]oxazol-6-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.784; RSBRXBZGVHQUJK-UHFFFAOYSA-N; [M+FA-H]-; 5-ethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.763; CASHNMDDCIRNQZ-UHFFFAOYSA-N; [M+FA-H]-; 5-methyl-1-nitrosopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.752; ADLADNOVIJYIMA-UHFFFAOYSA-N; [M+FA-H]-; 1-nitrosopiperidin-4-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.737; ZKMLNFVUVVWVCD-UHFFFAOYSA-N; [M+FA-H]-; 1-(5-methyl-1,2,4-oxadiazol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.736; RFTORHYUCZJHDO-UHFFFAOYSA-N; [M+FA-H]-; 1,3-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; SUWGHSHLNOADHI-UHFFFAOYSA-N; [M-H]-; 3,6-bis(hydroxymethyl)piperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.692; BBXKZVVSSHFHRQ-UHFFFAOYSA-N; [M+FA-H]-; 5-(2-aminoethyl)-1,2-oxazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.651; XCFHOYKWHOGMNG-UHFFFAOYSA-N; [M+FA-H]-; (3-ethyl-1,2,4-oxadiazol-5-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.648; NPXFBJIDOATJDZ-UHFFFAOYSA-N; [M+FA-H]-; methyl 4,5-dihydro-3H-pyrazole-3-carboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.639; APZVGCQAWIFTFI-UHFFFAOYSA-N; [M+FA-H]-; 5-(methylaminomethyl)-1,2-oxazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.635; OFMRSMZKZLPANF-UHFFFAOYSA-N; [M-H]-; dimethyl 1-methyldiaziridine-3,3-dicarboxylate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.629; UDPCOOPICFDMFC-UHFFFAOYSA-N; [M+FA-H]-; ethyl N-cyano-N-methylcarbamate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.608; LKMGDZMCCPSUFI-PLNGDYQASA-N; [M+FA-H]-; (2Z)-2-(nitromethylidene)pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.573; OJYJSOKMXFZINL-UHFFFAOYSA-N; [M+FA-H]-; methyl 2-(cyanomethylamino)acetate
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.571; OWJVEZJJRYZWNI-UHFFFAOYSA-N; [M-H]-; 1,1-dinitrocyclohexane
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.506; IVMFFAPHOPXMAD-UHFFFAOYSA-N; [M+FA-H]-; (3-methoxy-1,2-oxazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.484; DHODEGXCIINYFQ-UHFFFAOYSA-N; [M+FA-H]-; (5-methoxy-1,3-oxazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.440; NSGHSLTXCFWAIT-UHFFFAOYSA-N; [M+FA-H]-; 2-methyl-2-nitrobutanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.339; QXXCDDWJKVBBAF-UHFFFAOYSA-N; [M+FA-H]-; 3,5-dimethoxy-1H-pyrazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -93.531; HWYGBPPFPNZPGQ; [M+CH2O2-H]-; Citraconamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -98.303; XIZGHTQDCULLAQ; [M+CH2O2-H]-; (E)-pent-2-enediamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -104.515; HXFOXFJUNFFYMO; [M-H]-; Oprea1_301531
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -106.858; WGOIHPRRFBCVBZ; [M+CH2O2-H]-; 5-oxoprolinamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -108.799; JGBOVFKUKBGAJQ; [M+CH2O2-H]-; Itaconamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -112.577; NRXIKWMTVXPVEF; [M-H]-; formimino-glu
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.446; GYNOMCDGHQHGHJ; [M+CH2O2-H]-; 1-methylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -117.334; LPQUIFIUJKZJRT; [M+CH2O2-H]-; Hydrouracil, 1-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -121.159; ICCHEGCKVBMSTF; [M+CH2O2-H]-; Cyclo(ala-gly)
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -122.543; KZVYITBTXCMVDP; [M+CH2O2-H]-; 4-Methyl-2,6-piperazinedione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -125.961; GOFALJDPGWIYKL; [M+CH2O2-H]-; [1,3]Diazepan-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -131.853; WXKVEQXAOQPAKO; [M+CH2O2-H]-; 1-Methyl-2,3-piperazinedione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -133.869; DCGWMLJPCYQFKA; [M-H]-; L-Glutamic acid, N-(iminomethyl)-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -139.733; XQLIRTZXJDEQAO; [M+CH2O2-H]-; t6mvmvtj f1
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -147.252; NPWMTBZSRRLQNJ; [M+CH2O2-H]-; aminoglutarimide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -152.401; XNJHLZCLSPEUJN; [M+CH2O2-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -153.981; BJSCOTHGFJMOOE; [M+CH2O2-H]-; 5-oxopyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -158.030; MTZDUNZYSCZQFT; [M+CH2O2-H]-; 1,5-dimethylimidazolidine-2,4-dione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -159.763; WLTXUKAQFBTJKS; [M-H]-; Formylisoglutamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -161.360; DXWQLTOXWVWMOH; [M+CH2O2-H]-; 4-amino-4-cyanobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -164.618; KZUBZCHAWPDYQX; [M+CH2O2-H]-; N-(2-Cyanoethyl)glycine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -169.578; CZGXZAVXMRSVLV; [M+CH2O2-H]-; n-carbamoyl-2-methylacrylamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -172.821; RNHFRBDAMXTSCX; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.947; ZCASHLUDUSAKNN; [M-H]-; Acetyl-Gly-Gly
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -176.102; NBAKTGXDIBVZOO; [M+CH2O2-H]-; Dihydrothymine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.540; VZSTVUJXUYNIOQ; [M+CH2O2-H]-; AmbotzHAA5700
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.316; MTXZWQPKPBJVKF; [M-H]-; (2S)-2-amino-3-[(1R,2R)-2-nitrocyclopropyl]propanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -191.834; JYEMHOTUCUFTLO; [M+CH2O2-H]-; Hydantoin, 1-ethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.898; YIROYDNZEPTFOL; [M+CH2O2-H]-; Dantoin 736
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -194.157; ISXAJCKCTSMILF; [M-H]-; 4-acetamido-2-amino-4-oxobutanoate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.443; ADLADNOVIJYIMA; [M+CH2O2-H]-; Nitroso-4-piperidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.048; XYVMBSCIEDOIJQ; [M+CH2O2-H]-; squamolone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -210.935; XZFMJVJDSYRWDQ; [M-H]-; Tocris-1208
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -213.864; JUUCOMWMUXIJNP; [M+CH2O2-H]-; 2,2-Dimethyl-4,5-imidazolidinedione
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -214.734; CASHNMDDCIRNQZ; [M+CH2O2-H]-; N-Nitroso-5-methyl-2-pyrrolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -218.580; JJWACYUTERPMBM; [M+CH2O2-H]-; N-Acetylethyleneurea-d4
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -227.687; OBAUAYUJIDVRDI; [M+CH2O2-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -239.057; WIBZLKZAIBFAFQ; [M+CH2O2-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.343; NSGHSLTXCFWAIT; [M+CH2O2-H]-; 2-methyl-2-nitrobutanenitrile
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.314; QYHZCEGUXLBLDG; [M-H]-; 1-Amino-2-nitrocyclopentanecarboxylic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.197; XNIFBFLYOMFDJD; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -259.076; ONBXAYCDFSTCFM; [M+CH2O2-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -262.142; AHGQESFVDCNOGJ; [M+CH2O2-H]-; ethyl(cyanomethyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -264.238; SUWGHSHLNOADHI; [M-H]-; NSC 508753;Serine, bimol. cyclic peptide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -270.843; FAMRKDQNMBBFBR; [M-H]-; Diethyl azodiformate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -282.104; OWJVEZJJRYZWNI; [M-H]-; 1,1-Dinitrocyclohexane
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -295.967; APZVGCQAWIFTFI; [M+CH2O2-H]-; N-Methylmuscimol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -298.111; NVNPOFYSSSAIFL; [M-H]-; 1-Nitro-DL-pipecolic acid
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -308.330; PTCJTFARHUBUJI; [M-H]-; Diazocarboxylic acid ethyl ester
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -319.558; OXSJRTPNEMJVKX; [M-H]-; Amino sugar U 7
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -322.164; FOFPBSAVHBTASA; [M-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -325.263; NZRGMYXITFOSJS; [M+CH2O2-H]-; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -365.552; XAZYOVBOFGJZAL; [M+CH2O2-H]-; 3-Propylsydnone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -379.148; KOKQIXISIOUXJI; [M-H]-; ethyl N-nitroso-N-(3-oxopropyl)carbamate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -380.222; OFMRSMZKZLPANF; [M-H]-; dimethyl 1-methyldiaziridine-3,3-dicarboxylate
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -393.704; MOPOHBGHMCTYJK; [M+CH2O2-H]-; 3-Isopropylsydnone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -399.064; HZSZBZLCMBKMOU; [M-H]-; N-Methyl-N-(acetoxy-2-oxopropyl)nitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -400.167; WBBIYRQDHZMMPN; [M-H]-; N-Acetoxymethyl-N-2-oxopropylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -415.388; IVFVSTOFYHUJRU; [M-H]-; L-beta-Imidazolelactic Acid, Monohydrate
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.209; HXFOXFJUNFFYMO; [M-H]-; Oprea1_301531
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.149; HWYGBPPFPNZPGQ; [M+CH2O2-H]-; Citraconamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -73.775; OGYYSMAGRWSNGI; [M-H]-; (2S)-5-amino-2-formamido-5-oxopentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -102.859; ICCHEGCKVBMSTF; [M+CH2O2-H]-; Cycloglycylalanine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -105.348; HWYGBPPFPNZPGQ; [M+CH2O2-H]-; 2-methylbut-2-enediamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -108.443; GYNOMCDGHQHGHJ; [M+CH2O2-H]-; 1-Methylpiperazine-2,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.012; JGBOVFKUKBGAJQ; [M+CH2O2-H]-; 2-methylidenebutanediamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.076; LAEXPJQUWCGDGC; [M+CH2O2-H]-; 1-Methylpiperazine-2,6-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -120.479; XZQFGMJAIGQKHP; [M+CH2O2-H]-; N-(2-oxopyrrolidin-3-yl)formamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -125.303; WGOIHPRRFBCVBZ; [M+CH2O2-H]-; 5-oxopyrrolidine-2-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -126.071; BJSCOTHGFJMOOE; [M+CH2O2-H]-; 5-Oxopyrrolidine-3-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -128.468; WXKVEQXAOQPAKO; [M+CH2O2-H]-; 1-Methylpiperazine-2,3-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -133.784; KVBIYVVSEMYGPF; [M-H]-; (2S)-2,6-diamino-5,6-dioxohexanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -134.092; VHJBLXUVGPXMOM; [M-H]-; 2-(Carbamoylamino)-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -137.290; JUUCOMWMUXIJNP; [M+CH2O2-H]-; 2,2-Dimethylimidazolidine-4,5-dione
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -153.638; OEAODTGJRPLMHY; [M-H]-; (2S)-2-amino-5-formamido-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -166.539; DCGWMLJPCYQFKA; [M-H]-; 2-(2-methylidenehydrazin-1-yl)pentanedioic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -178.585; XAMDSZGFMCJXKV; [M-H]-; 5-Amino-2-carbamoyl-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -190.903; HXFOXFJUNFFYMO; [M-H]-; 3-carbamoyl-2-acetamidopropanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -194.423; VZLNYUXXGZZEEL; [M-H]-; 2-[(4-Amino-4-oxobutyl)amino]-2-oxoacetic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -195.171; SMBXQUAYXIEPEH; [M-H]-; 2,5-Diamino-2-formyl-5-oxopentanoic acid
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -197.103; NRXIKWMTVXPVEF; [M-H]-; N-Formimidoyl-L-Glutamate(2-)
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.482; OGYYSMAGRWSNGI; [M-H]-; (2S)-5-amino-2-formamido-5-oxopentanoate
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.194; ICCHEGCKVBMSTF; [M+CH2O2-H]-; Cycloglycylalanine
COMMENT: CONFIDENCE Level 5: Exact mass of interest 173.057151; Observed in MS1; Charge state -1;
CH$NAME: Uncharacterized
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Plasma
AC$INSTRUMENT: Agilent 1290 liquid chromatography system, Agilent Technologies - TripleTOF 6600+ mass spectrometer, AB SCIEX
AC$INSTRUMENT_TYPE: LC-ESI-QTOF
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE NEGATIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 30 eV
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE -4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 20.00; MS2(ppm) 20.00
AC$CHROMATOGRAPHY: COLUMN_NAME ACQUITY UPLC BEH C18 column (1.7 µm, 2.1 mm x 100 mm; Waters)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 7.0 min: 65, 8.0 min: 40, 9.0 min: 40, 9.1 min: 95, 12.0 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.5 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 5.080
MS$FOCUSED_ION: PRECURSOR_M/Z 173.057151
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-0006-9200000000-a2986c56cc94486010a8
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  44.0139222 999.0000 ? 44.013920 6.6343 46.93 1.0000 54
  54.0342138 54.3458 ? 54.034200 9.8086 20.69 0.7578 55
  58.0296296 67.5527 ? 58.029610 8.1510 31.58 0.6768 49
  70.0287560 35.3619 ? 70.028715 8.3966 15.18 0.6854 54
  83.0605353 217.7198 ? 83.060485 7.1153 47.86 0.8475 68
  84.0444703 120.5209 ? 84.044420 7.2224 42.12 0.7996 63
  101.0711175 82.2343 ? 101.071070 7.1930 23.71 0.8016 63
  109.0396297 75.5998 ? 109.039585 9.1435 30.85 0.6246 56
  111.0554138 192.8155 ? 111.055370 7.5458 56.33 0.8284 68
  127.0504148 66.5561 ? 127.050380 8.5006 23.39 0.7678 62
  128.0344891 33.9259 ? 128.034455 8.9898 12.98 0.5883 60
PK$NUM_PEAK: 11
PK$PEAK: m/z int. rel.int.
  44.013922 999.00 999
  54.034214 54.35 54
  58.029630 67.55 67
  70.028756 35.36 35
  83.060535 217.72 217
  84.044470 120.52 120
  101.071117 82.23 82
  109.039630 75.60 75
  111.055414 192.82 192
  127.050415 66.56 66
  128.034489 33.93 33
//
